According to ⁠American Cancer Society,⁠ Cancer causes about 1 in every 6 deaths globally, more than AIDS, tuberculosis, and malaria combined. Today, it is the first or second leading cause of death in most countries around the world. Technological advances in genomics have enabled the identification and improved understanding of causal factors and shed light on precision oncology.

In this episode, Dr. Marie-Laure Yaspo from ALACRIS Theranostics is working towards closing the care gap with evidence-based strategies in cancer control along the care continuum, from prevention to treatment, with help from MGI’s cutting-edge life science technologies.